Show simple item record

dc.contributor.authorSchifano, Fabrizio
dc.contributor.authorCorkery, John
dc.contributor.authorCuffolo, G.
dc.date.accessioned2007-10-15T13:04:15Z
dc.date.available2007-10-15T13:04:15Z
dc.date.issued2007
dc.identifier.citationSchifano , F , Corkery , J & Cuffolo , G 2007 , ' Smokable ( ice , crystal meth ) and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK ' , Annali dell'Istituto Superiore di Sanita , vol. 43 , no. 1 , pp. 110-115 .
dc.identifier.issn0021-2571
dc.identifier.otherPURE: 183545
dc.identifier.otherPURE UUID: 518caec8-16a7-4103-bf32-a9bdc862ef77
dc.identifier.otherdspace: 2299/909
dc.identifier.otherScopus: 34250645420
dc.identifier.urihttp://hdl.handle.net/2299/909
dc.description.abstract“Ice”, “crystal meth”, is the smokable form of methamphetamine hydrochloride. This paper will comment on the pharmacological, epidemiological, clinical and social issues related to smoking the drug as opposed to either its injection or ingestion. Furthermore, some data related to amphetamines/methamphetamines consumption, request for treatment, seizures, related offences and deaths in the UK (1990-2002) will be offered here. Peak rates, for most indicators, were reached at the end of the ’90s, to fall down in the following years. The only indicator which seemed not to show any declining rates is number of deaths, but this may be related to a more general increase in stimulant death rates recently observed in the UK. It is argued that methamphetamines, and particularly “crystal meth”, could reach the same prevalence levels of use in the UK as it is already in the US but recent reclassification of the drug to Class A in the UK could help to better control this emerging issue.en
dc.language.isoeng
dc.relation.ispartofAnnali dell'Istituto Superiore di Sanita
dc.titleSmokable ( ice , crystal meth ) and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UKen
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.contributor.institutionPrescription and Illicit Drug Misuse
dc.contributor.institutionPublic Health
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record